| Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation RG Hart, LA Pearce, MI Aguilar Annals of internal medicine 146 (12), 857-867, 2007 | 6641 | 2007 |
| Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis RG Hart, O Benavente, R McBride, LA Pearce Annals of internal medicine 131 (7), 492-501, 1999 | 2516 | 1999 |
| Selecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirin. BF Gage, L Pearce, RG Hart, PJ Koudstaal, BS Boode, P Petersen Circulation 110 (16), 2287-2292, 2004 | 984 | 2004 |
| Stroke with intermittent atrial fibrillation: incidence and predictors during aspirin therapy RG Hart, LA Pearce, RM Rothbart, JH McAnulty, RW Asinger, JL Halperin, ... Journal of the American College of Cardiology 35 (1), 183-187, 2000 | 948 | 2000 |
| Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II Study JL Halperin, RG Hart, RA Kronmal, R McBride, LA Pearce, DG Sherman The Lancet 343 (8899), 687-691, 1994 | 914 | 1994 |
| Blood-pressure targets in patients with recent lacunar stroke: the SPS3 randomised trial SPS3 Study Group The Lancet 382 (9891), 507-515, 2013 | 822 | 2013 |
| Independent predictors of stroke in patients with atrial fibrillation: a systematic review Stroke Risk in Atrial Fibrillation Working Group Neurology 69 (6), 546-554, 2007 | 788 | 2007 |
| Predictive value of cardiac troponin I and T for subsequent death in end-stage renal disease FS Apple, MAM Murakami, LA Pearce, CA Herzog Circulation 106 (23), 2941-2945, 2002 | 743 | 2002 |
| Transesophageal echocardiographic correlates of clinical risk of thromboembolism in nonvalvular atrial fibrillation M Zabalgoitia, JL Halperin, LA Pearce, JL Blackshear, RW Asinger, ... Journal of the American College of Cardiology 31 (7), 1622-1626, 1998 | 725 | 1998 |
| Factors associated with ischemic stroke during aspirin therapy in atrial fibrillation: analysis of 2012 participants in the SPAF I–III clinical trials RG Hart, LA Pearce, R McBride, RM Rothbart, RW Asinger Stroke 30 (6), 1223-1229, 1999 | 722 | 1999 |
| Predictors of thromboembolism in atrial fibrillation: II. Echocardiographic features of patients at risk Stroke Prevention in Atrial Fibrillation Investigators Annals of Internal Medicine 116 (1), 6-12, 1992 | 590 | 1992 |
| Predictors of thromboembolism in atrial fibrillation: I. Clinical features of patients at risk Stroke Prevention in Atrial Fibrillation Investigators Annals of Internal Medicine 116 (1), 1-5, 1992 | 528 | 1992 |
| Avoiding central nervous system bleeding during antithrombotic therapy: recent data and ideas RG Hart, SB Tonarelli, LA Pearce Stroke 36 (7), 1588-1593, 2005 | 489 | 2005 |
| Pathophysiologic correlates of thromboembolism in nonvalvular atrial fibrillation: I. Reduced flow velocity in the left atrial appendage (The Stroke Prevention in Atrial … ME Goldman, LA Pearce, RG Hart, M Zabalgoitia, RW Asinger, R Safford, ... Journal of the American Society of Echocardiography 12 (12), 1080-1087, 1999 | 463 | 1999 |
| Prognostic value of plasma von Willebrand factor and soluble P-selectin as indices of endothelial damage and platelet activation in 994 patients with nonvalvular atrial … DSG Conway, LA Pearce, BSP Chin, RG Hart, GYH Lip Circulation 107 (25), 3141-3145, 2003 | 404 | 2003 |
| Oral anticoagulants versus antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no history of stroke or transient ischemic attacks MI Aguilar, R Hart, LA Pearce Cochrane Database of Systematic Reviews, 2006 | 356 | 2006 |
| Diagnosis of ST-elevation myocardial infarction in the presence of left bundle branch block with the ST-elevation to S-wave ratio in a modified Sgarbossa rule SW Smith, KW Dodd, TD Henry, DM Dvorak, LA Pearce Annals of emergency medicine 60 (6), 766-776, 2012 | 353 | 2012 |
| Cardioembolic vs. noncardioembolic strokes in atrial fibrillation: frequency and effect of antithrombotic agents in the stroke prevention in atrial fibrillation studies RG Hart, LA Pearce, VT Miller, DC Anderson, JF Rothrock, GW Albers, ... Cerebrovascular diseases 10 (1), 39-43, 2000 | 349 | 2000 |
| Lessons from the stroke prevention in atrial fibrillation trials RG Hart, JL Halperin, LA Pearce, DC Anderson, RA Kronmal, R McBride, ... Annals of Internal Medicine 138 (10), 831-838, 2003 | 324 | 2003 |
| Multi-biomarker risk stratification of N-terminal pro-B-type natriuretic peptide, high-sensitivity C-reactive protein, and cardiac troponin T and I in end-stage renal disease … FS Apple, MAM Murakami, LA Pearce, CA Herzog Clinical chemistry 50 (12), 2279-2285, 2004 | 294 | 2004 |
